Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing.
Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing.
复制标题
孟鲁司特,一种半胱氨酰白三烯信号传导的拮抗剂,损害烧伤伤口愈合。
DOI:
10.1097/prs.0000000000009228
复制
发表时间:
2022-07-01
影响因子:
3.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Burns are severe injuries often associated with impaired wound healing. Impaired healing is caused by multiple factors including dysregulated inflammatory responses at the wound site. Interestingly, montelukast, an antagonist for cysteinyl leukotrienes (cysLTs) and FDA-approved for treatment of asthma and allergy, was previously shown to enhance healing in excision wounds and to modulate local inflammation. In this study, we examined the effect of montelukast in wound healing in a mouse model of scald burn injury. Burn wound tissues isolated from montelukast- and vehicle-treated mice at various times after burn injury were analyzed for wound areas (n=34–36), re-epithelialization (n=14), inflammation (n=8–9) and immune cell infiltration (n=3–6), and proliferation (n=7–8). In contrast to previously described beneficial effects in excision wounds, this study shows that montelukast delays burn wound healing by impairing the proliferation of keratinocytes and endothelial cells. This occurs largely independently of inflammatory responses at the wound site, suggesting that montelukast impairs specifically the proliferative phase of wound healing, in burns. Wound healing rates in mice in which leukotrienes are not produced were not affected by montelukast. Montelukast delays wound healing mainly by reducing the proliferation of local cells after burn injury.
影响因子:
3.7
作者:
Foster HR;Fuerst E;Lee TH;Cousins DJ;Woszczek G
通讯作者:
Woszczek G